E-mail: bd@sidmexinovia.com
Telefone: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Idrofos 6 mg Injection
Manufacturer/Marketed By : Sun Pharmaceutical Industries Ltd
$34.62 $27.00
Idrofos 6 mg Injection is a vital treatment option designed to prevent skeletal complications, such as fractures, in patients with breast cancer that has metastasized to the bones. This medication...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Ibandronic acid 6 mg
Active Pharmaceutical Ingredient
Idrofos 6 mg Injection
US$ 34,62
US$ 27,00
Idrofos 6 mg Injection is a vital treatment option designed to prevent skeletal complications, such as fractures, in patients with breast cancer that has metastasized to the bones. This medication is particularly beneficial for women experiencing osteoporosis after menopause, as it strengthens bones and reduces the risk of fractures. By working to inhibit bone resorption, Idrofos enhances bone density and helps maintain skeletal integrity. Clinical evidence suggests that this injection effectively lowers the risk of spinal fractures, although it does not provide a similar protective effect for femoral neck fractures. It is essential for patients to discuss their medical history and any existing conditions with their healthcare provider before starting this treatment. While Idrofos offers significant benefits, potential side effects and interactions should be carefully considered. With its dual role in managing both cancer-related bone issues and osteoporosis, Idrofos 6 mg Injection is a crucial component of comprehensive patient care in oncology and women's health.
Active Pharmaceutical Ingredient
Usos
• Idrofos 6 mg injection is utilized in the prevention of skeletal events in patients with breast cancer and bone metastases. This treatment helps reduce the risk of fractures and other bone complications associated with the spread of cancer to the bones. By administering Idrofos 6 mg injection, healthcare providers aim to improve the quality of life for these patients. This proactive approach is essential in managing the skeletal health of individuals facing such serious conditions.
• Another important use of Idrofos 6 mg injection is in the prevention of osteoporosis in postmenopausal women. After menopause, women are at increased risk of developing brittle bones, which can lead to fractures. Idrofos 6 mg injection helps to maintain bone density and strength during this vulnerable period. It is often recommended for women who are identified as being at risk for osteoporosis-related complications.
• Idrofos 6 mg injection may also be indicated for patients undergoing certain cancer treatments that affect bone health. These treatments can lead to weakened bones, making it crucial to provide supportive care to prevent skeletal complications. By incorporating Idrofos 6 mg injection into the treatment regimen, healthcare providers can help mitigate the adverse effects on bone integrity. This is particularly important for those with a history of bone-related issues.
• Additionally, Idrofos 6 mg injection plays a role in the management of bone health in patients with other malignancies that may lead to skeletal complications. The injection helps to fortify bones and reduce the likelihood of fractures in these individuals. By addressing the skeletal concerns associated with cancer, Idrofos 6 mg injection contributes to a comprehensive treatment strategy. This ensures that patients receive well-rounded care during their illness.
Benefícios
Idrofos 6 mg Injection belongs to a group of medicines called 'bisphosphonates' which are used for the prevention of osteoporosis after menopause. It is used in adults to prevent skeletal events such as pathological fractures and bone complications requiring surgery or radiotherapy in patients with bone metastases or breast cancer. Idrofos 6 mg can also be used to reduce hypocalcaemia (a high level of calcium in the blood). Idrofos 6 mg Injection works by suppressing the activity of the osteoclasts and making the bones stronger. It helps reduce the risk of fracturing and helps reduce pain. Idrofos Injection can reverse bone loss by increasing bone mass and stopping further bone loss.
Efeitos colaterais
Most side effects do not require medical attention and will go away as your body gets used to the medicine. Tell your doctor or health care professional if any of these symptoms get serious or if they bother you for a long time.
Efeitos colaterais mais comuns
• Fever
• Tiredness
• Hives
• Nausea
• Indigestion
• Diarrhoea
• Heartburn
• Joint and Muscle Pain
Efeitos colaterais comuns
• Dizziness
• Inflammation in Eye
• Stomach Pain
• Irritation in Tongue, Lips, and Throat
• Asthma
• Vomiting
Como usar
Idrofos 6 mg Injection is administered by a doctor or nurse in a hospital or clinic setting. The appropriate dosage and frequency of use will be determined by your doctor, taking into account the specific condition being treated. You must follow your doctor's instructions exactly when taking this medicine. Failure to do so or taking an excessive amount may result in serious side effects. The beneficial effects of this medicine may take several weeks or months to manifest, but it is important not to stop taking it unless instructed to do so by your doctor. It is advised to avoid alcohol as it may increase the risk of liver damage. Self-administration of this Idrofos 6 mg is strictly prohibited.
Conselhos de segurança
• Alcohol: Drinking alcohol while taking Idrofos 6 mg Injection is generally not recommended. It can increase the risk of liver damage, so it is best to avoid alcohol or limit the amount of alcohol you drink while you are taking any of the medicines.
• Kidney: No dose adjustment is necessary for patients with mild or moderate kidney disease, where creatinine clearance is equal to or greater than 30 ml/min. Severe kidney disease patients do not use this Idrofos Injection.
• Breastfeeding: Breastfeeding while taking Idrofos 6 mg is not recommended. It is possible that Idrofos Injection may pass into breast milk and harm a baby. If you are breastfeeding and taking Idrofos Injection, it is important that you talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Liver: Idrofos 6 mg is considered safe for use in liver disease patients. No dose adjustment is needed for such a type of patient.
• Pregnancy: The use of Idrofos 6 mg Injection during pregnancy may be unsafe as there is some evidence from animal studies that it may harm the developing foetus. However, it is important to discuss the potential risks and benefits of taking Idrofos 6 mg Injection during pregnancy with your doctor if you are pregnant or planning to become pregnant. Your doctor can help you make the best decision for you and the health of your baby.
• Driving: Idrofos 6 mg Injection does not usually affect your ability to drive.
Isenção de responsabilidade
A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.
Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.
Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.
Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.